Stockscreener 앱 받기
460.72
1.32%
5.98
시간 외 거래:
460.72
전일 마감가:
$454.74
열려 있는:
$453.49
하루 거래량:
1.69M
Relative Volume:
0.61
시가총액:
$173.92B
수익:
$43.21B
순이익/손실:
$6.58B
주가수익비율:
26.65
EPS:
17.29
순현금흐름:
$6.17B
1주 성능:
-0.50%
1개월 성능:
+8.11%
6개월 성능:
-19.38%
1년 성능:
-23.22%
1일 변동 폭
$451.44
$461.72
1주일 범위
$446.28
$469.87
52주 변동 폭
$385.46
$627.88
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
TMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Thermo Fisher: The Rerating Is Just Getting StartedBuy (NYSE:TMO) - Seeking Alpha
Thermo Fisher Scientific Stock (TMO) Opinions on $2 Billion Investment Plan - Quiver Quantitative
Oligonucleotide CDMO Market to Soar USD 18.37 Billion at 21.83% Strong CAGR by 2034 - GlobeNewswire Inc.
U.S. Active Pharmaceutical Ingredients CDMO Market Report 2025-2030 | Competitive Analysis of Thermo Fisher Scientific, Novo Group, Cambrex, Piramal, Corden, Siegfried, Seqens, SK, Noramco, BSP - Yahoo Finance
Thermo Fisher shells out $97m to expand clinical research labs - BioXconomy
Thermo Fisher Unveils Next-Gen Electron Microscopes for Enhanced Lab Efficiency - Lab Manager
Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets (TMO) - Seeking Alpha
Fund Update: PARNASSUS INVESTMENTS, LLC added 744,827 shares of THERMO FISHER SCIENTIFIC ($TMO) to their portfolio - Quiver Quantitative
Cell Line Development Market Outlook Report 2025-2034: - GlobeNewswire
Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry - Yahoo Finance
Thermo Fisher launches two microscopes - Scientist Live
Drug Screening Market Is Booming So Rapidly 2025-2032 -Thermo - openPR.com
Kovitz Core Equity Strategy Boosts Position in Thermo Fisher Scientific Amidst Tariff Uncertainty - AInvest
Here’s Why Kovitz Core Equity Strategy Increased Its Position in Thermo Fisher Scientific (TMO) - Insider Monkey
Proteomics Market Top PlayersThermo Fisher Scientific, Inc. - openPR.com
Thermo Fisher Scientific Falls 0.03% as $920M Volume Ranks 93rd on Strong Institutional Buying and Upgraded Analyst Targets - AInvest
Thermo Fisher plots 85 layoffs in California as its cost-cutting crusade marches on - Fierce Pharma
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Insider Monkey
Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends - sg.finance.yahoo.com
Proteomics Market Growth and Future Scope 2025-2032 | Thermo - openPR.com
Thermo Fisher Scientific introduces Applied Biosystems MagMAX HMW DNA Kit - European Pharmaceutical Manufacturer
Energy giant GE Vernova's market cap is now the largest in Mass. - The Business Journals
Thermo Fisher: New Headwinds Could Delay The Industry's Recovery (NYSE:TMO) - Seeking Alpha
Contract Manufacturing Market Forecast to 2030, with Case Studies of Thermo Fisher Scientific and Flextronics - GlobeNewswire
What makes Thermo Fisher Scientific Inc. stock price move sharplyFree Stock Market Forecast Reports - Jammu Links News
Does Thermo Fisher Scientific Inc. stock perform well during market downturnsBuild a winning investment strategy - Jammu Links News
What are the latest earnings results for Thermo Fisher Scientific Inc.Invest like a pro with expert recommendations - Jammu Links News
What is the dividend policy of Thermo Fisher Scientific Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
What catalysts could drive Thermo Fisher Scientific Inc. stock higher in 2025Breakout stock performance - Jammu Links News
Is Thermo Fisher Scientific Inc. stock overvalued or undervaluedStrong return on investment - jammulinksnews.com
How does Thermo Fisher Scientific Inc. generate profit in a changing economyExplosive trading opportunities - jammulinksnews.com
How does Thermo Fisher Scientific Inc. compare to its industry peersExplosive market performance - Jammu Links News
Stifel Reaffirms Buy on Thermo Fisher (TMO) Despite Price Target Cut - MSN
Thermo Fisher 2025 Q2 Earnings Strong Performance as Net Income Grows 4% - AInvest
THERMO FISHER SCIENTIFIC INC. SEC 10-Q Report - TradingView
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation - Yahoo Finance
Why Thermo Fisher Scientific Inc. stock attracts strong analyst attentionMomentum Based Equity Trading Plans Reviewed - beatles.ru
Here’s Why Thermo Fisher Scientific (TMO) Traded Down in Q2 - MSN
Global G-Protein Coupled Receptors Market [2025-2032] - openPR.com
Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific - Yahoo Finance
Drug Abuse Testing Market Forecast and Company Analysis - GlobeNewswire
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance
5 Insightful Analyst Questions From Thermo Fisher’s Q2 Earnings Call - TradingView
Thermo Fisher Margins Feel The Weight Of Tariffs Even As China Trade Pressures Ease In Q2 - insights.citeline.com
Thermo Fisher's Q2 revenue and EPS beat estimates, driven by Life Sciences Solutions growth and strong product launches. - AInvest
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ... - Yahoo Finance
Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450 - MSN
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now - MSN
Thermo Fisher Scientific showcases diagnostics solutions designed to meet evolving global healthcare demands at ADLM 2025 - SelectScience
North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - Yahoo Finance
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
자본화:
|
볼륨(24시간):